Pharmaceutical Marketing News

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... - MarketWatch (press release)



Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... 
MarketWatch (press release)
About Auxilium Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of ...

and more » 


China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints ... - MarketWatch (press release)



China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints ... 
MarketWatch (press release)
BEIJING, May 21, 2012 (GlobeNewswire via COMTEX) -- China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales ...
Source: China Nuokang Bio-Pharmaceutical Inc. GlobeNewsWire (press release)

all 2 news articles » 


FDA approves Teva's generic version of blood thinner Plavix - New York Daily News



CBS News
 
FDA approves Teva's generic version of blood thinner Plavix 
New York Daily News
Teva, Mylan Inc. (NYSE: MYL), Apotex Corporation, Roxane Laboratories Inc. of the US, India's Sun Pharmaceutical Industries Ltd. (BSE: 524715) Aurobindo Pharma Ltd. (BSE: 524804) and Torrent Pharmaceuticals, obtained marketing approval for 75 milligram ...
Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US market Economic Times
Mylan Launches Generic Version of Plavix® Tablets MarketWatch (press release)
Dr Reddy's introduces generic version of Plavix in US Pharmaceutical Business Review

all 288 news articles » 


Sagent Pharma launches Atracurium Besylate injection in US - pharmabiz.com



Sagent Pharma launches Atracurium Besylate injection in US 
pharmabiz.com
Sagent Pharmaceuticals, Inc. has launched Atracurium Besylate Injection, USP, the generic form of the neuromuscular blocker Tracrium, in 50 mg per 5 mL latex-free vials. According to IMS data for the twelve-months ended March 2012, the US market for ...

 


Teva board makes Frost's announcement earlier this month official when they ... - Haaretz



Teva board makes Frost's announcement earlier this month official when they ... 
Haaretz
Putting the issue on the table might have been his way of publicly daring potential rivals to overthrow a chairman with a proven track record in the pharma industry and with strong US capital market contacts, in favor of an unknown, at a sensitive time ...

and more » 


Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical ... - MarketWatch (press release)



Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical ... 
MarketWatch (press release)
EWING, NJ, May 15, 2012 (BUSINESS WIRE) -- Antares Pharma, Inc. (ASE:AIS) today announced the appointment of LeRoux Jooste to the position of Senior Vice President of Pharmaceutical Sales and Marketing. Mr. Jooste has more than 25 years of experience ...
Antares Pharma Appoints LeRoux Jooste SVP Pharmaceutical Sales and Marketing Citybizlist (press release)

all 7 news articles » 


Pharma sales rise 20pc, outlook bright - Daily Star Online



Pharma sales rise 20pc, outlook bright 
Daily Star Online
The sector recorded Tk 8788 crore in sales turnover in the 12 months through March, according to the Intercontinental Marketing Services (IMS), a market research company that provides data on markets, especially on the healthcare industry.

 


Research and Markets: Comparisons of Pharmaceutical Manufacturing between ... - PharmiWeb.com (press release)



Research and Markets: Comparisons of Pharmaceutical Manufacturing between ... 
PharmiWeb.com (press release)
They have been seeking the balances between innovative drugs and generic drugs in their product portfolios and between the developed markets and the emerging markets in their market focuses. As a result, almost all pharma companies have been gradually ...

and more » 


Organovo Appoints Dr. Eric Michael David As Chief Strategy Officer - MarketWatch (press release)



Organovo Appoints Dr. Eric Michael David As Chief Strategy Officer 
MarketWatch (press release)
Dr. David was most recently associate partner at the consultancy McKinsey & Company, where he served private equity, pharmaceutical, biotech, diagnostic, and medical device clients to support pipeline and R&D strategy, as well as market entry strategy.

 


Arena and Eisai Expand Marketing and Supply Agreement for Lorcaserin - MarketWatch (press release)



AFP
 
Arena and Eisai Expand Marketing and Supply Agreement for Lorcaserin 
MarketWatch (press release)
SAN DIEGO and WOODCLIFF LAKE, NJ, May 10, 2012 /PRNewswire via COMTEX/ -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced today the expansion of the lorcaserin marketing and supply agreement between Arena Pharmaceuticals, ...
Arena extends lorcaserin marketing alliance with Eisai Pharmaceutical Business Review

all 653 news articles »